Used off-label for lung and breast cancer and Kaposi’s sarcoma, bexarotene binds to RXRs (RXRα, RXRβ, and RXRγ), activating these ligand-activated transcription factors to regulate gene expression. Here, RXRG is linked to breast carcinoma.